Curative Biotechnology, Inc.
OTC: CUBT0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- I. Richard Garr
- Employees
- 4
- Headquarters
- Palm Beach Gardens, United States
- IPO year
- 1998
- Market cap
- $7.4M
- Website
- https://curativebiotech.com
Loading CUBT…
Loading profile data…Frequently asked questions about CUBT
What does Curative Biotechnology, Inc. (CUBT) do?
Curative Biotechnology, Inc. is an emerging biomedical firm primarily focused on developing pharmaceutical products. Its research and development efforts are concentrated on a diverse pipeline targeting critical therapeutic areas, including infectious diseases, cancer, and vision-impairing degenerative eye conditions. Among its key pipeline asse...
Where does CUBT trade?
Curative Biotechnology, Inc. (CUBT) trades on the Other OTC.
What sector is CUBT in?
Curative Biotechnology, Inc. (CUBT) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Curative Biotechnology, Inc.?
I. Richard Garr is the chief executive officer of Curative Biotechnology, Inc. (CUBT).
Where is Curative Biotechnology, Inc. headquartered?
Curative Biotechnology, Inc. is headquartered in United States.
Does CUBT pay a dividend?
Curative Biotechnology, Inc. (CUBT) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CUBT go public?
Curative Biotechnology, Inc. (CUBT) completed its initial public offering in 1998.